市场调查报告书
商品编码
1470753
电子医疗/生物电子医疗市场:按产品、设备、应用和最终用户分类 - 2024-2030 年全球预测Electroceuticals/Bioelectric Medicine Market by Product, Device, Application, End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年电子医疗/生物电子医疗市场规模为250.6亿美元,2024年达270.5亿美元,2030年预计将达432.8亿美元,复合年增长率为8.11%。
电药或生物电医学是指使用电脉衝调节人体神经迴路作为药物替代品的治疗方法。这种创新方法利用神经系统控制身体器官功能的先天能力,影响各种生理和病理状况。电疗的基本原理是精确地向特定神经发送电信号以调节其活动并治疗各种疾病。老年人口的增加、心臟疾病和神经系统疾病的盛行率以及对非侵入性治疗的偏好正在推动电疗和生物电製药市场的成长。然而,与电疗相关的技术复杂性阻碍了其普及。生物电医学领域不断的技术创新,例如设备的小型化和电池寿命的提高,以及生物电医学的进步使个性化治疗计划成为可能,有利于电医学或生物电医学市场的扩大,为您提供了巨大的机会。
主要市场统计 | |
---|---|
基准年[2023] | 250.6亿美元 |
预测年份 [2024] | 270.5亿美元 |
预测年份 [2030] | 432.8亿美元 |
复合年增长率(%) | 8.11% |
产品由于心血管疾病的流行,对心臟心律调节器和植入式心臟整流去颤器的需求不断增加
心臟心律调节器和植入式心臟整流去颤器对于心律不整的治疗至关重要。当心臟的自然心律调节器失效时,心律调节器可以维持适当的心率。植入式心臟整流去颤器(ICD) 是一种心臟心律调节器,是一种先进的设备,可以透过电击纠正危及生命的心律不整并防止心因性猝死。人工电子耳是一种电子医疗设备,可以取代受损内耳的功能。人工电子耳绕过内耳受损的毛细胞,向大脑发送声音讯号,对于重度听力损失患者恢復听力至关重要。深层脑部刺激器主要用于治疗神经系统疾病,如帕金森氏症、肌张力不全症和自发性震颤,并向大脑的特定部位发送电脉衝。视网膜植入是为因老龄化黄斑部病变(AMD)和色素性视网膜炎等视网膜疾病而视力严重受损的人製造的,它们通过替代眼睛中受损的感光细胞来发挥作用。视网膜植入透过将入射光转换成电讯号并将其发送到大脑来部分恢復视力。脊髓刺激设备旨在缓解慢性疼痛。脊髓刺激设备使用低压电流在疼痛讯号到达大脑之前阻止它们。迷走神经刺激设备针对迷走神经,迷走神经从大脑穿过颈部到达腹部,调节许多身体功能。迷走神经刺激设备主要用于治疗癫痫和忧郁症,分别向神经发送电脉衝以稳定异常的脑电活动和情绪。
应用:扩大电疗疗法用于治疗慢性疼痛的应用
电製剂透过有针对性的电刺激调节心律,为治疗心律不整提供了一种有前景的方法。植入式心臟整流去颤器(ICD) 和心律调节器等设备提供精确的电脉衝以维持或恢復正常心律,是治疗的基石。脊髓刺激 (SCS) 和经皮神经电刺激 (TENS) 等电疗法已显示出对慢性疼痛治疗的功效。这些方法的作用是在疼痛讯号到达大脑之前改变它们,为对药物治疗反应不佳的患者提供另一种选择。在癫痫治疗中,迷走神经刺激设备(VNS)等向迷走神经发送週期性电脉衝的装置可以帮助减少对药物治疗无反应的患者癫痫发作的严重程度和频率,具有显着的效用。电疗药物在帕金森氏症治疗方面取得了突破,特别是深部脑部刺激(DBS)。透过向大脑的特定部位提供电刺激,DBS 有助于控制帕金森氏症的运动症状,例如震颤、僵硬和移动困难。视网膜假体或视网膜植入是生物电子医学的先进型态,可为色素性视网膜炎患者型态视力恢復。这些设备透过将外部光转换为电信号并将其发送到大脑来为用户提供视觉。人工电子耳对于感音性听障患者来说是一项重要的电生理应用。这些设备绕过耳朵中受损的毛细胞,直接刺激听觉神经,让您感知声音并大大提高您的沟通能力。
区域洞察
由于先进的医疗基础设施、对研发的重视以及高昂的医疗成本,美洲的电子医疗/生物电子医疗市场正在成长。心血管疾病、神经系统疾病和糖尿病等慢性疾病在美洲很普遍,增加了电疗解决方案的需求。此外,在美国,医疗机构和高科技公司之间的合作正在推动创新和更先进、更有针对性的电疗治疗方法的开发。由于医疗基础设施的迅速改善、可支配收入的增加以及对先进医疗保健意识的不断增强,亚太地区电子医疗/生物电子医疗市场正在不断增长。亚太地区人口老化和慢性病患者较多,是电疗的重要应用领域。欧洲、中东和非洲地区是一个多元化且不断发展的电子医疗/生物电子医疗市场,其特征是欧洲成熟的医疗保健系统以及中东和非洲的新兴市场。凭藉严格的法律规范、高医疗标准和对研究的高度重视,欧洲在电疗领域的发展中发挥关键作用。在中东,医疗基础设施投资不断扩大,对尖端医疗技术的兴趣不断增加。由于人们对非药物治疗选择的认识不断提高以及改善医疗保健系统的努力,非洲地区显示出成长潜力。
FPNV定位矩阵
FPNV定位矩阵对于评估电子医疗/生物电子医疗市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对电子医疗/生物电子医疗市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4.竞争评估及资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行综合评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1. 电子医疗/生物电子医疗市场的市场规模与预测是多少?
2.在电子医疗/生物电子医疗市场的预测期内,有哪些产品、细分市场、应用和领域需要考虑投资?
3.电子医疗/生物电子医疗市场的技术趋势和法规结构是什么?
4.电子医疗/生物电子医疗市场主要厂商的市场占有率是多少?
5. 进入电子医疗/生物电子医疗市场的适当型态和策略手段是什么?
[194 Pages Report] The Electroceuticals/Bioelectric Medicine Market size was estimated at USD 25.06 billion in 2023 and expected to reach USD 27.05 billion in 2024, at a CAGR 8.11% to reach USD 43.28 billion by 2030.
Electroceuticals, or bioelectric medicine, refer to a therapeutic modality that uses electrical impulses to modulate the body's neural circuits as an alternative to pharmaceuticals. This innovative approach exploits the nervous system's inherent capability to govern the body's organ functions, influencing various physiological and pathological conditions. The fundamental principle behind electroceuticals involves precisely delivering electrical signals to specific nerves, aiming to adjust their activity to treat various medical conditions. The growing elderly population, the prevalence of cardiac and neurological disorders, and the rising preference for non-invasive treatments drive the growth of the electroceuticals or bioelectric medicine market. However, the technological complexities associated with electroceuticals hinder their adoption. The ongoing innovation in bioelectric medicine, including the miniaturization of devices and improvements in battery life, and advancements in bioelectric medicine that allow for personalized treatment plans offer lucrative opportunities for the expansion of the electroceuticals or bioelectric medicine market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 25.06 billion |
Estimated Year [2024] | USD 27.05 billion |
Forecast Year [2030] | USD 43.28 billion |
CAGR (%) | 8.11% |
Product: Increasing need for cardiac pacemakers and implantable cardioverter defibrillators owing to the prevalence of cardiovascular diseases
Cardiac pacemakers & implantable cardioverter defibrillator devices are critical in managing heart rhythm disorders. Pacemakers maintain an adequate heart rate when the heart's natural pacemaker is dysfunctional. Implantable cardioverter defibrillators (ICDs) are advanced devices that pace the heart and deliver shocks to correct life-threatening arrhythmias, thus preventing sudden cardiac death. Cochlear implants are electronic medical devices replacing the function of the damaged inner ear. Cochlear implants bypass damaged hair cells of the inner ear for providing sound signals to the brain, and are integral in restoring hearing in individuals with profound hearing loss. Deep brain stimulators are utilized primarily to treat neurological conditions such as Parkinson's disease, dystonia, and essential tremors, and they send electrical pulses to specific parts of the brain. Retinal implants are tailored for individuals with severe vision loss due to retinal diseases, including age-related macular degeneration (AMD) and retinitis pigmentosa; retinal implants work by substituting the damaged photoreceptor cells in the eye. Retinal implants convert incoming light into electrical signals, which are then sent to the brain, thereby partially restoring vision. Spinal cord stimulators are designed to alleviate chronic pain; spinal cord stimulators emit low-voltage electrical currents to interrupt pain signals before reaching the brain. Vagus nerve stimulator devices target the vagus nerve, running from the brain through the neck and into the abdomen, modulating numerous body functions. Vagus nerve stimulators are primarily used to treat epilepsy and depression, delivering electrical impulses to the nerve to stabilize abnormal electrical brain activity and mood, respectively.
Application: Growing adoption of electroceuticals to manage chronic pain conditions
Electroceuticals offer a promising approach to managing arrhythmias by modulating heart rhythms through targeted electrical stimulation. Devices, including implantable cardioverter defibrillators (ICDs) and pacemakers, have become cornerstone treatments, providing precise electrical impulses to maintain or restore normal heart rhythm. In chronic pain management, electroceutical interventions such as spinal cord stimulation (SCS) and transcutaneous electrical nerve stimulation (TENS) have shown effectiveness. These methods work by altering pain signals before they reach the brain, offering an alternative for patients who might not respond well to pharmacological therapies. In epilepsy treatment, devices such as the vagus nerve stimulator (VNS) demonstrate significant utility by regularly delivering electrical impulses to the vagus nerve, helping reduce the severity and frequency of seizures in patients unresponsive to medication. Electroceuticals have made strides in Parkinson's disease management, notably through deep brain stimulation (DBS). By delivering electrical stimuli to specific areas in the brain, DBS can help control motor symptoms of Parkinson's disease, such as tremors, stiffness, and difficulty moving. An advanced form of bioelectric medicine, the artificial retina or retinal implants offer a form of sight restoration for individuals with retinitis pigmentosa. These devices convert external light into electrical signals, which are then sent to the brain, helping to provide the user with a form of visual perception. Cochlear implants represent a pivotal electroceutical application in sensorineural hearing loss cases. These devices bypass damaged hair cells within the ear to directly stimulate the auditory nerve, allowing individuals to perceive sound and significantly improving communication abilities.
Regional Insights
The Americas experiences growth in the electroceuticals/bioelectric medicine market, attributed to advanced healthcare infrastructure, strong emphasis on research and development, and high healthcare expenditure. The prevalence of chronic diseases, including cardiovascular disorders, neurological ailments, and diabetes in the Americas, fuels the need for electroceutical solutions. Additionally, partnerships between medical institutions and tech companies in the U.S. foster innovation and facilitate the development of more sophisticated and targeted electroceutical therapies. The Asia-Pacific region's electroceuticals/bioelectric medicine market is growing, driven by rapidly improving healthcare infrastructure, increasing disposable incomes, and a growing awareness of advanced medical treatments. The Asia-Pacific region's growing aging population presents a substantial patient pool for chronic diseases and significant electroceutical application areas. The EMEA region presents a diverse and evolving market for electroceuticals/bioelectric medicine, characterized by well-established healthcare systems in Europe and emerging markets in the Middle East and Africa. With its stringent regulatory framework, high healthcare standards, and a strong emphasis on research, Europe plays a crucial role in advancing the electroceutical field. The Middle East witnesses growing investments in healthcare infrastructure and an increasing inclination toward advanced medical technologies. The African region showcases the potential for growth due to rising awareness of non-pharmaceutical treatment options and efforts to improve healthcare systems.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Electroceuticals/Bioelectric Medicine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Electroceuticals/Bioelectric Medicine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Electroceuticals/Bioelectric Medicine Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aleva Neurotherapeutics SA, Bioinduction Ltd., BIOTRONIK SE & Co. KG, BioWave Corporation, Boston Scientific Corporation, CEFALY Technology sprl, Cochlear Limited, electroCore, Inc., Galvani Bioelectronics by GSK PLC, Gimer Medical Co., Ltd., LivaNova PLC, MED-EL Elektromedizinische Gerate GmbH, Medtronic PLC, NeuroPace, Inc., Nevro Corp., Oticon Medical, Second Sight Medical Products, Inc., and Sonova Holding AG.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Electroceuticals/Bioelectric Medicine Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Electroceuticals/Bioelectric Medicine Market?
3. What are the technology trends and regulatory frameworks in the Electroceuticals/Bioelectric Medicine Market?
4. What is the market share of the leading vendors in the Electroceuticals/Bioelectric Medicine Market?
5. Which modes and strategic moves are suitable for entering the Electroceuticals/Bioelectric Medicine Market?